Literature DB >> 12009062

Prognostic significance of a new histologic grading system for canine osteosarcoma.

J Kirpensteijn1, M Kik, G R Rutteman, E Teske.   

Abstract

Histologic grade is an important determinant in clinical outcome of human osteosarcoma (OS). In this study, the histologic characteristics of primary and metastatic canine OS were evaluated using a new classification system. Histologic characteristics were classified in 166 primary and 34 metastatic canine OS. Prognostic variables for clinical outcome were determined using multivariate analysis. Most OS were histologically characterized by severe to extreme cellular pleomorphism, a variable number of mitoses, small to moderate amounts of matrix, a high percentage of tumor cells, and minimal to moderate amounts of necrosis. Tumor invasion into vessels was present in 117/152 (71%) tumors, and 12/50 (24%) of the regional lymph nodes had evidence of metastasis. Classification of the 166 tumors resulted in seven (4%) grade 1, 34 (21%) grade II, and 125 (75%) grade III OS. In the multivariate analysis, histologic grade III OS and elevated pretreatment plasma alkaline phosphatase (AP) levels were independent predictors of clinical outcome. Dogs with high-grade tumors and elevated AP should be carefully evaluated for the presence of metastatic disease before starting adjunctive therapy protocols.

Entities:  

Mesh:

Year:  2002        PMID: 12009062     DOI: 10.1354/vp.39-2-240

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  36 in total

1.  Fibroblastic osteosarcoma with epithelioid and squamous differentiation in a dog.

Authors:  Tiffany L Jenkins; Dalen Agnew; Daniel R Rissi
Journal:  J Vet Diagn Invest       Date:  2018-04-09       Impact factor: 1.279

2.  Heat shock protein expression in canine osteosarcoma.

Authors:  Mariarita Romanucci; Giuliana D'Amato; Daniela Malatesta; Laura Bongiovanni; Chiara Palmieri; Andrea Ciccarelli; Paolo Buracco; Emanuela Morello; Lorella Maniscalco; Raffaella De Maria; Marina Martano; Leonardo Della Salda
Journal:  Cell Stress Chaperones       Date:  2011-10-21       Impact factor: 3.667

3.  Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: a randomized, phase III trial.

Authors:  K A Skorupski; J M Uhl; A Szivek; S D Allstadt Frazier; R B Rebhun; C O Rodriguez
Journal:  Vet Comp Oncol       Date:  2013-10-04       Impact factor: 2.613

4.  Evaluation of outcome and prognostic factors for dogs living greater than one year after diagnosis of osteosarcoma: 90 cases (1997-2008).

Authors:  William T N Culp; Francisco Olea-Popelka; Jennifer Sefton; Charles F Aldridge; Stephen J Withrow; Mary H Lafferty; Robert B Rebhun; Michael S Kent; Nicole Ehrhart
Journal:  J Am Vet Med Assoc       Date:  2014-11-15       Impact factor: 1.936

Review 5.  Canine sarcomas as a surrogate for the human disease.

Authors:  Daniel L Gustafson; Dawn L Duval; Daniel P Regan; Douglas H Thamm
Journal:  Pharmacol Ther       Date:  2018-03-09       Impact factor: 12.310

6.  Distribution and activity levels of matrix metalloproteinase 2 and 9 in canine and feline osteosarcoma.

Authors:  Christiane Gebhard; Andrea Fuchs-Baumgartinger; Ebrahim Razzazi-Fazeli; Ingrid Miller; Ingrid Walter
Journal:  Can J Vet Res       Date:  2016-01       Impact factor: 1.310

7.  Heat shock protein expression analysis in canine osteosarcoma reveals HSP60 as a potentially relevant therapeutic target.

Authors:  Gayathri T Selvarajah; Floor A S Bonestroo; Jolle Kirpensteijn; Marja J L Kik; Ruurd van der Zee; Willem van Eden; Elpetra P M Timmermans-Sprang; Adri Slob; Jan A Mol
Journal:  Cell Stress Chaperones       Date:  2013-03-06       Impact factor: 3.667

8.  Influence of genetic background on tumor karyotypes: evidence for breed-associated cytogenetic aberrations in canine appendicular osteosarcoma.

Authors:  Jaime F Modiano; Matthew Breen; Rachael Thomas; Huixia J Wang; Pei-Chien Tsai; Cordelia F Langford; Susan P Fosmire; Cristan M Jubala; David M Getzy; Gary R Cutter
Journal:  Chromosome Res       Date:  2009-04-01       Impact factor: 5.239

Review 9.  Research models and mesenchymal/epithelial plasticity of osteosarcoma.

Authors:  Xiaobin Yu; Jason T Yustein; Jianming Xu
Journal:  Cell Biosci       Date:  2021-05-22       Impact factor: 7.133

10.  Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times.

Authors:  Gayathri T Selvarajah; Jolle Kirpensteijn; Monique E van Wolferen; Nagesha A S Rao; Hille Fieten; Jan A Mol
Journal:  Mol Cancer       Date:  2009-09-07       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.